-
1دورية أكاديمية
المساهمون: Sung-Gyu Lee, Long-Bin Jeng, Faouzi Saliba, Arvinder Singh Soin, Wei-Chen Lee, Paolo De Simone, Frederik Nevens, Kyung-Suk Suh, Lutz Fischer, Dong Jin Joo, John Fung, Jae-Won Joh, Toshimi Kaido, David Grant, Matthias Meier, Barbara Rauer, Carole Sips, Shuhei Kaneko, Gary Levy, Joo, Dong Jin
مصطلحات موضوعية: Adult, Calcineurin Inhibitors / administration & dosage, Calcineurin Inhibitors / adverse effects, Carcinoma, Hepatocellular / diagnosis, Hepatocellular / surgery, Drug Therapy, Combination, Everolimus / administration & dosage, Everolimus / adverse effects, Female, Glomerular Filtration Rate / drug effects, Graft Rejection / diagnosis, Graft Rejection / immunology, Graft Rejection / prevention & control, Graft Survival / drug effects, Humans, Immunosuppressive Agents / administration & dosage, Immunosuppressive Agents / adverse effects, Kidney / drug effects, Kidney / physiopathology, Liver Neoplasms / diagnosis, Liver Neoplasms / surgery, Liver Transplantation* / adverse effects, Male, Middle Aged, Randomized Controlled Trials as Topic, Recurrence, Tacrolimus / administration & dosage, Tacrolimus / adverse effects
العلاقة: TRANSPLANTATION; J02754; OAK-2021-08802; https://ir.ymlib.yonsei.ac.kr/handle/22282913/187238Test; T202105332; TRANSPLANTATION, Vol.105(7) : 1564-1575, 2021-07
الإتاحة: https://doi.org/10.1097/TP.0000000000003394Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/187238Test -
2دورية أكاديمية
المساهمون: Robert Motzer, Boris Alekseev, Sun-Young Rha, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Grünwald, Thomas E Hutson, Evgeny Kopyltsov, María J Méndez-Vidal, Vadim Kozlov, Anna Alyasova, Sung-Hoo Hong, Anil Kapoor, Teresa Alonso Gordoa, Jaime R Merchan, Eric Winquist, Pablo Maroto, Jeffrey C Goh, Miso Kim, Howard Gurney, Vijay Patel, Avivit Peer, Giuseppe Procopio, Toshio Takagi, Bohuslav Melichar, Frederic Rolland, Ugo De Giorgi, Shirley Wong, Jens Bedke, Manuela Schmidinger, Corina E Dutcus, Alan D Smith, Lea Dutta, Kalgi Mody, Rodolfo F Perini, Dongyuan Xing, Toni K Choueiri, Rha, Sun Young
مصطلحات موضوعية: Adult, Aged, 80 and over, Antibodies, Monoclonal, Humanized / administration & dosage, Humanized / adverse effects, Antineoplastic Agents / adverse effects, Antineoplastic Agents / therapeutic use, Antineoplastic Combined Chemotherapy Protocols / adverse effects, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Carcinoma, Renal Cell / drug therapy, Renal Cell / mortality, Everolimus / administration & dosage, Everolimus / adverse effects, Female, Humans, Kidney Neoplasms / drug therapy, Kidney Neoplasms / mortality, Male, Middle Aged, Phenylurea Compounds / administration & dosage, Phenylurea Compounds / adverse effects, Programmed Cell Death 1 Receptor / antagonists & inhibitors, Progression-Free Survival, Protein Kinase Inhibitors / therapeutic use, Quinolines / administration & dosage, Quinolines / adverse effects, Sunitinib / adverse effects
العلاقة: NEW ENGLAND JOURNAL OF MEDICINE; J02371; OAK-2021-06182; https://ir.ymlib.yonsei.ac.kr/handle/22282913/185460Test; T202104165; NEW ENGLAND JOURNAL OF MEDICINE, Vol.384(14) : 1289-1300, 2021-04
الإتاحة: https://doi.org/10.1056/NEJMoa2035716Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/185460Test -
3دورية أكاديمية
المساهمون: Franco Citterio, Mitchell Henry, Dean Y Kim, Myoung Soo Kim, Duck-Jong Han, Takashi Kenmochi, Eytan Mor, Giuseppe Tisone, Peter Bernhardt, Maria Pilar Hernandez Gutierrez, Yoshihiko Watarai, Kim, Myoung Soo
مصطلحات موضوعية: Adult, Calcineurin Inhibitors / administration & dosage, Calcineurin Inhibitors / adverse effects, Everolimus / administration & dosage, Everolimus / adverse effects, Female, Humans, Immunosuppressive Agents / administration & dosage, Immunosuppressive Agents / adverse effects, Incidence, Kidney Transplantation, Lymphocele / epidemiology, Lymphocele / etiology, Male, Middle Aged, Mycophenolic Acid / administration & dosage, Mycophenolic Acid / adverse effects, Risk, Surgical Wound Dehiscence / epidemiology, Surgical Wound Dehiscence / etiology, Wound Healing / drug effects, Calcineurin inhibitor, everolimus, randomized, safety, wound healing
العلاقة: EXPERT OPINION ON DRUG SAFETY; J03925; OAK-2021-05745; https://ir.ymlib.yonsei.ac.kr/handle/22282913/185010Test; T999202325; EXPERT OPINION ON DRUG SAFETY, Vol.19(10) : 1339-1348, 2020-10
الإتاحة: https://doi.org/10.1080/14740338.2020.1792441Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/185010Test -
4دورية أكاديمية
المساهمون: College of Medicine, Dept. of Internal Medicine, Kyong Joo Lee, Jae Hee Cho, Sang Hyub Lee, Si Young Song, Kwang Hyuk Lee, Seok Jeong, Ji Kon Ryu, Sang Myung Woo, Seungmin Bang, Jong Kyun Lee, Tae Hoon Lee, Woo Hyun Paik, Yong Tae Kim, Woo Jin Lee, Bang, Seung Min, Song, Si Young
مصطلحات موضوعية: Adult, Aged, 80 and over, Anemia/chemically induced, Anemia/epidemiology, Antineoplastic Agents/adverse effects, Antineoplastic Agents/therapeutic use, Disease-Free Survival, Everolimus/adverse effects, Everolimus/therapeutic use, Exanthema/chemically induced, Exanthema/epidemiology, Female, Humans, Male, Middle Aged, Neoplasm Grading, Neoplasm Recurrence, Local, Pancreatic Neoplasms/drug therapy, Pancreatic Neoplasms/pathology, Prognosis, Republic of Korea, Retrospective Studies, Stomatitis/chemically induced, Stomatitis/epidemiology, Treatment Outcome, Young Adult, Everolimus, Pancreatic neuroendocrine tumor
العلاقة: CANCER CHEMOTHERAPY AND PHARMACOLOGY; J00437; OAK-2017-05183; https://ir.ymlib.yonsei.ac.kr/handle/22282913/160894Test; https://link.springer.com/article/10.1007%2Fs00280-017-3421-7Test; T201703544; CANCER CHEMOTHERAPY AND PHARMACOLOGY, Vol.80(4) : 799-805, 2017
الإتاحة: https://doi.org/10.1007/s00280-017-3421-7Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/160894Test -
5دورية أكاديمية
المساهمون: College of Medicine, Dept. of Internal Medicine, S. J. Kim, D.-Y. Shin, J. S. Kim, D. H. Yoon, W. S. Lee, H. Lee, Y. R. Do, H. J. Kang, H. S. Eom, Y. H. Ko, S. H. Lee, H. Y. Yoo, M. Hong, C. Suh, W. S. Kim, Kim, Jin Seok
مصطلحات موضوعية: Adult, Aged, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Cyclophosphamide/administration & dosage, Cyclophosphamide/adverse effects, Disease-Free Survival, Doxorubicin/administration & dosage, Doxorubicin/adverse effects, Drug Administration Schedule, Everolimus/administration & dosage, Everolimus/adverse effects, Female, Humans, Lymphoma, T-Cell, Peripheral/drug therapy, Peripheral/pathology, Male, Middle Aged, Neoplasm Staging, PTEN Phosphohydrolase/biosynthesis, PTEN Phosphohydrolase/genetics, Prednisone/administration & dosage, Prednisone/adverse effects, TOR Serine-Threonine Kinases/antagonists & inhibitors, TOR Serine-Threonine Kinases/genetics, Treatment Outcome, Vincristine/administration & dosage, Vincristine/adverse effects
العلاقة: ANNALS OF ONCOLOGY; J00171; OAK-2016-07707; https://ir.ymlib.yonsei.ac.kr/handle/22282913/152779Test; T201605305; ANNALS OF ONCOLOGY, Vol.27(4) : 712-718, 2016
الإتاحة: https://doi.org/10.1093/annonc/mdv624Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/152779Test -
6دورية أكاديمية
المؤلفون: Motzer, Robert, Alekseev, Boris, Rha, Sun-Young, Porta, Camillo, Eto, Masatoshi, Powles, Thomas, Grünwald, Viktor, Hutson, Thomas E, Kopyltsov, Evgeny, Méndez-Vidal, María J, Kozlov, Vadim, Alyasova, Anna, Hong, Sung-Hoo, Kapoor, Anil, Alonso Gordoa, Teresa, Merchan, Jaime R, Winquist, Eric, Maroto, Pablo, Goh, Jeffrey C, Kim, Miso, Gurney, Howard, Patel, Vijay, Peer, Avivit, Procopio, Giuseppe, Takagi, Toshio, Melichar, Bohuslav, Rolland, Frederic, De Giorgi, Ugo, Wong, Shirley, Bedke, Jens, Schmidinger, Manuela, Dutcus, Corina E, Smith, Alan D, Dutta, Lea, Mody, Kalgi, Perini, Rodolfo F, Xing, Dongyuan, Choueiri, Toni K, CLEAR Trial Investigators
المساهمون: Gennigens, Christine
المصدر: New England Journal of Medicine, 384 (14), 1289 - 1300 (2021-04-08)
مصطلحات موضوعية: Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Phenylurea Compounds, Programmed Cell Death 1 Receptor, Protein Kinase Inhibitors, Quinolines, Everolimus, pembrolizumab, lenvatinib, Sunitinib, Adult, Aged, Aged, 80 and over, Antibodies, Monoclonal, Humanized/administration & dosage, Antibodies, Monoclonal, Humanized/adverse effects, Antineoplastic Agents/adverse effects, Antineoplastic Agents/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Carcinoma, Renal Cell/drug therapy, Carcinoma, Renal Cell/mortality, Everolimus/administration & dosage, Everolimus/adverse effects, Female, Humans, Kidney Neoplasms/drug therapy, Kidney Neoplasms/mortality, Male, Middle Aged, Phenylurea Compounds/administration & dosage, Phenylurea Compounds/adverse effects, Programmed Cell Death 1 Receptor/antagonists & inhibitors, Progression-Free Survival, Protein Kinase Inhibitors/therapeutic use, Quinolines/administration & dosage, Quinolines/adverse effects, Sunitinib/adverse effects, Sunitinib/therapeutic use, Survival Analysis, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Renal Cell, Kidney Neoplasms, Medicine (all), General Medicine, Human health sciences, Oncology, Sciences de la santé humaine, Oncologie
العلاقة: http://www.nejm.org/doi/pdf/10.1056/NEJMoa2035716Test; urn:issn:0028-4793; urn:issn:1533-4406
الوصول الحر: https://orbi.uliege.be/handle/2268/300816Test
-
7دورية أكاديمية
المؤلفون: Pozdzik, Agnieszka, Fernandez Vallone, Valeria, Demetter, Pieter, Tooulou, Monika, Matos Pinto De Almeida, Celso, Gammar, Nadia, Broeders, Emine Nilufer, Dratwa, Max, Nortier, Joëlle
المصدر: Peritoneal dialysis international, 35 (7
مصطلحات موضوعية: Néphrologie - urologie, Everolimus -- adverse effects, Female, Glomerulonephritis, Membranoproliferative -- surgery, Humans, Immunosuppressive Agents -- adverse effects, Kidney Transplantation -- adverse effects, Peritoneal Fibrosis -- diagnosis -- etiology -- therapy, Young Adult
وصف الملف: 1 full-text file(s): application/pdf
العلاقة: uri/info:doi/10.3747/pdi.2014.00157; uri/info:pii/35/7/769; uri/info:pmid/26703854; uri/info:scp/84951288261; uri/info:pmcid/PMC4690640; https://dipot.ulb.ac.be/dspace/bitstream/2013/226649/3/PMC4690640.pdfTest; http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/226649Test